KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Asset Writedowns and Impairment (2018 - 2025)

Progyny (PGNY) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with $7.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A to $7.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $21.4 million, a N/A change, with the full-year FY2025 number at $20.5 million, up 25.19% from a year prior.
  • Asset Writedowns and Impairment was $7.8 million for Q4 2025 at Progyny, up from $5.7 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $7.8 million in Q4 2025 to a low of $2.3 million in Q1 2022.
  • A 5-year average of $4.1 million and a median of $4.1 million in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: soared 392.89% in 2021, then plummeted 39.98% in 2024.
  • Progyny's Asset Writedowns and Impairment stood at $2.6 million in 2021, then surged by 60.38% to $4.1 million in 2022, then rose by 18.57% to $4.9 million in 2023, then tumbled by 35.1% to $3.2 million in 2024, then soared by 146.43% to $7.8 million in 2025.
  • Per Business Quant, the three most recent readings for PGNY's Asset Writedowns and Impairment are $7.8 million (Q4 2025), $5.7 million (Q1 2025), and $3.2 million (Q3 2024).